When it comes to cancer studies, the published reviewed studies hold more weight academically. So when Universities start publishing studies showing ginger beats chemo by 10 times, we need to pay attention. Researchers are beginning to do the rigorous clinical studies pitting natural cancer killers against chemical ones.
One study, conducted by Georgia State University found that whole ginger extract was able to reduce the size of a prostate tumor by 56% in mice. In addition to its effect on cancer, ginger was also observed to reduce inflammation and supply the mice with life-enhancing antioxidants.
Another study published in PLoS found that one particular component in ginger known as 6-shogaol is superior to conventional cancer medication, namely chemotherapy, at targeting the root cause of breast cancer malignancy: breast cancer stem cells.
Sometimes referred to as ‘mother cells’, cancer stem cells are the cause of a wide range of cancers, not simply breast cancer. These ‘mother cells’ are responsible for creating the different ‘daughter’ cell types that makeup the tumor colony. While cancer stem cells only constitute .2 to 1% of the cell makeup of the tumor, they seem to be almost ‘immortal’.
The details can be a little complex but GreenMediaInfo has done a terrific job of summarizing them.
“In contrast [to 6-shagoal], taxol, even though was highly active in monolayer cells, did not show activity against the spheroids even at 10000 fold higher concentration compared to 6-shogoal.”
This is a highly significant finding, as it affirms a common theme in cancer research that acknowledges the primarily role of cancer stem cells: namely, while conventional techniques like surgery, radiation, and chemotherapy are effective at reducing a tumor’s size, sometimes to the point where it is “debulked,” burned,” or “poisoned” out of the body even below the threshold of re-detection, the appearance of “winning the battle” often comes at a steep price, as ultimately the cancer stem cell population regrows the tumors, now with increased vengeance and metastastic invasiveness, resulting in the cancer “winning the war.”
The monolayer model, which does not account for the complex immunity of actual cancer stem-cell based tumors against chemoagents like taxol, represents the old preclinical model of testing cancer treatments. The spheroid model, on the other hand, clearly shows that even 10,000 times higher concentrations of taxol are not capable of beating this ginger component at selectively targeting the root cause of the tumor malignancy.
In their concluding remarks, the authors point out a hugely important distinction between natural anti-cancer agents and conventional ones that have only been introduced in the past half century or so, namely, “Dietary compounds are welcome options for human diseases due to their time-tested acceptability by human bodies.”
Personally, I’d go with ginger any day. The concept that you try to kill all the cells within inches of death in hopes that you get the cancer cells while leaving enough of the body to recovery afterwards never made sense to me. If cancer is an error in the immune system that allows certain cells to grow out of control, why not fix the immune system instead of trying to kill it?
Images courtesy of Green Media Info.